Knight Therapeutics Inc. announces voting results from the Annual General Meeting
MONTREAL, May 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Corporation") a leading pan-American (ex-US) specialty pharmaceutical company, announced today the voting results from the Annual General Meeting of the Shareholders held virtually in Montreal, Quebec ("Meeting").
- MONTREAL, May 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Corporation") a leading pan-American (ex-US) specialty pharmaceutical company, announced today the voting results from the Annual General Meeting of the Shareholders held virtually in Montreal, Quebec ("Meeting").
- Each director nominee listed in the Management Information Circular dated April 6, 2023 ("Circular") was elected as Director of the Corporation at the Meeting.
- Shareholders present in person or represented by proxy at the Meeting voted as follows: